July 2011 Reports on several studies implicating a certain neuropeptide (a signaling molecule) in fostering addition and overeating and discusses implications for addiction treatment.
Reports on NIDA’s research priorities—drug abuse and addiction prevention, treatment, and HIV/AIDS—which will remain consistent during these challenging budget times.
July 2011 Reports on a new medication strategy under investigated in animal studies that shows promise for preventing relapse to drug abuse.
December 2010 Describes a study investigating the effectiveness of modafinil in enhancing sleep among cocaine abusers who are currently abstinent.
December 2010 Announces three new NIDA National Advisory Council on Drug Abuse members and describes their drug abuse and addiction research experience.
December 2010 Announces NIDA’s new director of its intramural research program, Antonello Bonci, M.D., a leading researcher in neuropsychopharmacology.
Reports on research investigating whether certain medications might strengthen patients' understanding and memory retention.
October 2010 Reports on two studies that demonstrate the promise of treating addiction with medications that alleviate drug-induced alterations in signaling by the neurotransmitter glutamate.
April 2010 Announces the appointment of Dr. Phil Skolnick as NIDA’s director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse.
November 2009 Describes research on the effectiveness of a buprenorphine patch to alleviate opioid withdrawal symptoms of newly abstinent heroin abusers.